Drug Discovery
dotted-divider

Xerra: A new imaging modality to study biodistribution

Cryo-fluorescence tomography (CFT) is an imaging technology that combines cryoslicing, high-resolution imaging and analysis software into one molecular imaging platform. This multispectral fluorescence imaging technique is important for ADME (absorption distribution, metabolism, excretion) and drug distribution studies. pharmacokinetic, and pharmacodynamic studies.

Biodistribution

CFT – high sensitivity, high specificity, faster processing in a laboratory setting

Radiolabeled pharmaceuticals and probes are common in the drug discovery world and take time and resources to develop. CFT offers unique advantages in the discovery phase by adding a streamlined imaging modality for drug characterization utilizing fluorescent reporters. CFT can provide valuable insight into absorption, distribution, metabolism and excretion (ADME) information and visualization of a whole animal in a cost-effective time sensitive manner. In addition, specific organs can be analyzed, and further characterization can be extrapolated from a study. Tissue sections can also be transferred to slides for histology.

Biodistribution in the spine

biodistribution-spine
Click for larger view.

Delivery of antisense (ASOs) labeled with Cy7 are evaluated in mouse brains.

Time course study shows biodistribution of ASOs over time.

The role of CFT in Biodistribution studies

Fluoro-tagged adeno-associated viruses (AAVs) are used to deliver genes to mammalian cells and express fluorescent marker proteins in animals. Specifically, CFT can be used to quantify fluorescence, and to differentiate different AAV strains, across the whole animal. This high-resolution confirmation is possible only through CFT technology.

dotted-divider

Absorption, Distribution, Metabolism, Visualization
ADME

CFT provides high sensitivity, high specificity and faster processing in any laboratory setting

Radiolabeled pharmaceuticals and probes are common in the drug discovery world and take time and resources to develop. CFT offers unique advantages in the discovery phase by adding a streamlined imaging modality for drug characterization utilizing fluorescent reporters. 

 

CFT can provide valuable insight into absorption, distribution, metabolism and excretion (ADME) information and visualization of a whole animal in a cost-effective time-sensitive manner. In addition, specific organs can be analyzed, and imaging data can be extrapolated for further characterization. 

 

Tissue sections can also be transferred to slides for histology.

Biodistribution of intrathecal tracer in kidney

Tracer A
applications-drug-discovery-tracerA
Click for larger view.
Image of kidney in rat model.
Tracer B
Click for larger view.

Two tracers – simultaneously

In a study of renal blood flow, renal clearance of 2 tracers, was measured simultaneously. 

 

Tracer A was intrathecally injected first and 50 minutes later, Tracer B was administered intravenously. A white light image was also taken for anatomical context and showed the segmented vascular structure of the kidney. 

 

A slice-by-slice overlay was viewed through our powerful software. 

 

3D renderings of renal fluorescence distribution and structural mapping showed the precise distribution of tracers.

The Next Generation of Imaging. Xerra.